#MEAction US protest demands

These demands were originally issued for the May 25, 2016 MillionsMissing demonstrations. Minor revisions were made to the demands in November 2016 to reflect community input on the definition, the primer, the name, and the need for improvements in clinical care.   You can access and download a pdf of the revised protest demands by clicking on the button below.

[button_color url=”http://meaction.net/wp-content/uploads/2016/11/Protest-Demands-November-2016.pdf” content=”Protest Demands” target=”http://meaction.net/wp-content/uploads/2016/11/Protest-Demands-November-2016.pdf”]
Facebook
Twitter
WhatsApp
Email

4 thoughts on “#MEAction US protest demands”

  1. I personally think it is a mistake not to have Fukuda with mandatory PEM as a selection of cohorts. CCC and ICC describe many with ME/CFS but not all and I would have met Fukuda early on in my disease but not CCC or ICC although I do meet them now. Fukuda and SEID (which I would have met at 6 months easily) are useful in early diagnosis for many before disease progression and meeting CCC and ICC criteria when you are usually disabled.
    Being disabled is no time to diagnose which is why it took me 25 years for diagnosis when I met CCC criteria. Fukuda was around but no doctor would go out on a limb then to Dx me and when I imploded it just so happened it was the same year CCC was created.
    Patients that are meeting SEID and Fukuda w/ mandatory PEM need to be studied and it just needs to be noted in the study which patients are meeting which criteria.

  2. And I think SEID should be used on a clinical level and the DePaul Filter used to put those who meet SEID into research. Then Fukuda w/ mandatory PEM, CCC w/ mandatory PEM or ICC (ICC will never happen I am sure) can be applied and should be noted in studies so grouped results can be researched. Some will meet all criteria, some one or two and that should be noted.
    But SEID should be used on a clinical level to diagnose everyone and then the other criteria can be used for severity. CCC and ICC Dx the disabled. SEID will Dx on a clinical level and hopefully proper treatment can be applied before they get to meeting CCC and ICC which I believe those that meet them are disabled.
    Also, CCC in the clinical world does not allow for a patient to have some other diseases which isn’t realistic.

Comments are closed.

Latest News

navy blue square. there are two white lines at the top and bottom of the square. The #MEAction logo in at the top of the image. The words #MEAction Georgia Voice of the Patient in coordination with the Center for Disease Control and Prevention & Emory School of Nursing.

#MEAction Georgia: Voice of the Patient in Coordination with CDC & Emory School on Nursing

Back in September, #MEAction Georgia State Chapter partnered with the Centers for Disease Control and Prevention (CDC) and Emory School of Nursing to host, Voice of the Patient: A Panel Discussion with #MEAction Georgia. This event was a continuation of #MEAction Georgia’s #MillionsMissing 2024: #TeachMETreatME programming. Erin Lee and Liz Burlingame of the #MEAction Georgia

Read More »
a light blue square image with medical instruments/tools as a border (pill bottles, scales, needles, covid protein spike, etc). At the top of the image is the Home Test to Treat Program logo, in blue font: Findings Summary. Below that the #MEAction logo and Body Politic Logo.

Home Test To Treat – Findings Summary

#MEAction and Body Politic collaborated last spring, with a new national telehealth program, Home Test to Treat. We are now able to share initial findings from the program! Here are some highlights: 80K + enrolled in the program across the country! 40K + test distributed 6K + individuals treated for COVID-19 or flu 5.6K+ organizations

Read More »
Scroll to Top